Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.12
- Piotroski Score 4.00
- Grade Outperform
- Symbol (EVH)
- Company Evolent Health, Inc.
- Price $11.46
- Changes Percentage (1.33%)
- Change $0.15
- Day Low $11.17
- Day High $11.54
- Year High $35.00
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $42.00
- High Stock Price Target $51.00
- Low Stock Price Target $28.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.26
- Trailing P/E Ratio -18.63
- Forward P/E Ratio -18.63
- P/E Growth -18.63
- Net Income $-113,040,000
Income Statement
Quarterly
Annual
Latest News of EVH
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ...
John Johnson, CFO, discussed the claims audit process, with a significant increase in flagged claims for review. $100 million rate adjustments by Jan 2025 are mostly prospective. New partnerships are ...
By Yahoo! Finance | 1 week ago -
Evolent Health (NYSE:EVH) shareholders are still up 260% over 5 years despite pulling back 4.0% in the past week
Evolent Health, Inc. (EVH) shares have dropped 17% in a month, despite a 260% gain in the last five years. The company's revenue growth of 24% annually has driven its stock price up by 29% yearly....
By Yahoo! Finance | 1 month ago -
Here's Why Evolent Health (EVH) is on the List of Bottom Securities of Carillon Eagle Small Cap Growth Fund
Carillon Tower Advisers' Q2 2024 investor letter discusses the performance of small-cap stocks, highlighting Evolent Health, Inc. as a promising investment. The fund sees potential in AI stocks for hi...
By Yahoo! Finance | 2 months ago
